The Emirates Drug Establishment (EDE) has approved Lipfendra, a medicine indicated for the treatment of adults with elevated low-density lipoprotein (LDL-C) cholesterol, including certain inherited conditions, as part of a treatment plan determined by a healthcare professional. With this approval, th. .



